HealthEquity, Inc. (NASDAQ:HQY) Shares Sold by GW&K Investment Management LLC

GW&K Investment Management LLC lowered its holdings in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 23.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 604,471 shares of the company's stock after selling 186,437 shares during the quarter. GW&K Investment Management LLC owned 0.70% of HealthEquity worth $57,999,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also made changes to their positions in HQY. Louisiana State Employees Retirement System raised its holdings in HealthEquity by 0.4% during the 4th quarter. Louisiana State Employees Retirement System now owns 24,200 shares of the company's stock valued at $2,322,000 after buying an additional 100 shares during the period. Oregon Public Employees Retirement Fund increased its position in HealthEquity by 0.6% during the fourth quarter. Oregon Public Employees Retirement Fund now owns 17,776 shares of the company's stock valued at $1,706,000 after acquiring an additional 100 shares during the last quarter. Raymond James Trust N.A. raised its stake in shares of HealthEquity by 4.8% in the third quarter. Raymond James Trust N.A. now owns 2,905 shares of the company's stock valued at $238,000 after acquiring an additional 132 shares during the period. CIBC Asset Management Inc lifted its holdings in shares of HealthEquity by 5.6% in the 4th quarter. CIBC Asset Management Inc now owns 2,640 shares of the company's stock worth $253,000 after acquiring an additional 139 shares during the last quarter. Finally, Sanctuary Advisors LLC boosted its position in shares of HealthEquity by 5.0% during the fourth quarter. Sanctuary Advisors LLC now owns 3,335 shares of the company's stock valued at $320,000 after buying an additional 159 shares during the period. 99.55% of the stock is owned by hedge funds and other institutional investors.

Remove Ads

Insider Buying and Selling

In other HealthEquity news, Director Robert W. Selander sold 5,750 shares of the company's stock in a transaction on Monday, February 10th. The shares were sold at an average price of $111.29, for a total value of $639,917.50. Following the sale, the director now directly owns 78,219 shares of the company's stock, valued at approximately $8,704,992.51. This represents a 6.85 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Stuart B. Parker sold 25,000 shares of the stock in a transaction dated Thursday, December 12th. The stock was sold at an average price of $96.72, for a total value of $2,418,000.00. Following the sale, the director now directly owns 19,061 shares in the company, valued at $1,843,579.92. This represents a 56.74 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 39,000 shares of company stock worth $3,895,788 in the last 90 days. Insiders own 2.20% of the company's stock.

HealthEquity Stock Down 1.7 %

Shares of NASDAQ:HQY traded down $1.83 during trading on Tuesday, reaching $102.99. The stock had a trading volume of 948,897 shares, compared to its average volume of 732,464. The firm's 50-day simple moving average is $105.33 and its 200 day simple moving average is $93.89. The company has a current ratio of 3.20, a quick ratio of 3.20 and a debt-to-equity ratio of 0.51. HealthEquity, Inc. has a one year low of $65.01 and a one year high of $115.59. The company has a market capitalization of $8.93 billion, a P/E ratio of 94.49, a PEG ratio of 1.60 and a beta of 0.55.

HealthEquity (NASDAQ:HQY - Get Free Report) last announced its earnings results on Monday, December 9th. The company reported $0.59 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.71 by ($0.12). HealthEquity had a net margin of 8.41% and a return on equity of 9.70%. During the same period last year, the business earned $0.40 EPS. As a group, research analysts expect that HealthEquity, Inc. will post 2.32 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on the stock. JMP Securities boosted their price objective on shares of HealthEquity from $105.00 to $107.00 and gave the company a "market outperform" rating in a research report on Tuesday, December 10th. Mizuho initiated coverage on HealthEquity in a report on Wednesday, December 4th. They issued an "outperform" rating and a $126.00 price target for the company. BTIG Research raised their price objective on HealthEquity from $110.00 to $130.00 and gave the stock a "buy" rating in a report on Thursday, November 14th. Wells Fargo & Company lifted their target price on HealthEquity from $110.00 to $125.00 and gave the company an "overweight" rating in a research report on Wednesday, February 26th. Finally, The Goldman Sachs Group initiated coverage on HealthEquity in a research report on Friday, November 15th. They set a "neutral" rating and a $108.00 price target on the stock. One analyst has rated the stock with a hold rating and twelve have given a buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $113.54.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.